StonvexLoading…
StonvexCore line items from FA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.57B | $860.21M | $763.76M | $810.02M |
Operating Income | $132.47M | $-62.38M | $81.52M | $94.28M |
Net Income | $-34.82M | $-110.27M | $37.29M | $64.60M |
EPS (Diluted) | $-0.20 | $-0.74 | $0.26 | $0.43 |
Total Assets | $3.83B | $3.92B | $1.63B | $1.89B |
Total Liabilities | $2.52B | $2.62B | $723.92M | $759.21M |
Cash & Equivalents | $240.00M | $168.69M | $213.77M | $391.65M |
Free Cash Flow OCF − CapEx | $188.49M | $26.48M | $160.74M | $206.60M |
Shares Outstanding | 174.19M | 173.17M | 145.07M | 148.73M |